• TRIMIPRAMINE MALEATE CHEMBL1200948 FDA Approved

    Alternate Names:

    Trimipramine Maleate
    Surmontil
    Tydamine
    Tripress
    Trimipramine-75 - Cap 75mg
    Trimipramine Tab 50mg
    Trimipramine Tab 25mg
    Trimipramine Tab 12.5mg
    Trimipramine Tab 100mg
    Trimineurin
    Trimidura
    Surmontil 75
    Surmontil 12.5
    Surmontil 100
    Stangyl
    Sapilent
    Rhotrimine
    Nu-trimipramine Tab 50mg
    Nu-trimipramine Tab 25mg
    Nu-trimipramine Tab 12.5mg
    Nu-trimipramine Tab 100mg
    Novo-tripramine Tab 50mg BP
    Novo-tripramine Tab 25mg BP
    Novo-tripramine Tab 100mg BP
    Herphonal
    Apo-trimipramine
    739-71-9
    beta-Methylimipramine
    Trimeproprimine
    Trimeprimine
    RP-7162
    10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine
    DB00726
    Trimipramine
    5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,BETA-TRIMETHYL-, (2Z)-2-BUTENEDIOATE (1:1)
    (Z)-BUT-2-ENEDIOIC ACID; 3-(5,6-DIHYDROBENZO[B][1]BENZAZEPIN-11-YL)-N,N,2-TRIMETHYLPROPAN-1-AMINE
    (2Z)-BUT-2-ENEDIOIC ACID; (3-{2-AZATRICYCLO[9.4.0.0?,?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YL}-2-METHYLPROPYL)DIMETHYLAMINE
    TRIMEPRIMINE MONOMALEATE
    (2Z)-BUT-2-ENEDIOIC ACID; (3-{2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YL}-2-METHYLPROPYL)DIMETHYLAMINE
    3-(5,6-DIHYDROBENZO[B][1]BENZAZEPIN-11-YL)-N,N,2-TRIMETHYL-PROPAN-1-AMINE; MALEIC ACID
    10,11-DIHYDRO-N,N,|A-TRIMETHYL-5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE (2Z)-2-BUTENEDIOATE
    3B3-057034
    D02408
    C14029
    EU-0101156
    LS-173816
    SMR000326720
    PL001324
    LS-60411
    AN-10861
    NCGC00094418-05
    NCGC00094418-04
    NCGC00094418-03
    NCGC00094418-02
    NCGC00094418-01
    NCGC00016013-06
    NSC-758386
    LP01156
    TRIMIPRAMINE MALEATE [USAN:USP:JAN]
    TOX21_110449_1
    NSC758386
    CCG-39308
    2768AH
    TOX21_110449
    HY-B1213
    PHARMAKON1600-01503117
    HMS3263H13
    HMS2233H17
    HMS2097B13
    HMS2092L08
    HMS1922G07
    HMS1570B13
    TRIMIPRAMINE MALEATE [USAN:JAN]
    TRIMIPRAMINE MALEATE (JAN/USAN)
    HMS500E15
    SPECTRUM1503117
    TRIMIPRAMINE MALEATE (1:1)
    MLS001056765
    SCHEMBL41289
    CAS-521-78-8
    NCGC00016483-01
    AC1NQZV7
    TRIMIPRAMINE (MALEATE)
    PRESTWICK_1022
    SURMONTIL (TN)
    S4416,521-78-8
    5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,BETA-TRIMETHYL-, (Z)-2-BUTENEDIOATE (1:1)
    CHEBI:35030
    5H-DIBENZ(B,F)AZEPINE, 10,11-DIHYDRO-5-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-, MALEATE (1:1)
    5-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPINE MALEATE (1:1)
    739-71-9 (PARENT)
    DSSTOX_GSID_45315
    DSSTOX_RID_80796
    DSSTOX_CID_25315
    EINECS 208-318-3
    C20H26N2.C4H4O4
    TRIMIPRAMINE HYDROGEN MALEATE
    TRIMIPRAMINE ACID MALEATE
    TRIMIPRAMIUM MALEINICUM
    TRIMIPRAMINI MALEAS
    521-78-8
    TRIMEPRIMINE MALEATE
    SURMONTIL MALEATE
    TRIMIPRAMINE MALEATE SALT
    5282318
    T 3146

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories serotonin modulators
    Drug Categories qtc-prolonging agents (indeterminate risk and risk modifying)
    Drug Categories psychotropic drugs
    Drug Categories psychoanaleptics
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories p-glycoprotein/abcb1 inhibitors
    Drug Categories non-selective monoamine reuptake inhibitors
    Drug Categories neurotransmitter uptake inhibitors
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories membrane transport modulators
    Drug Categories heterocyclic compounds, 3-ring
    Drug Categories heterocyclic compounds
    Drug Categories dibenzazepines
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories cytochrome p-450 cyp2c9 substrates
    Drug Categories cytochrome p-450 cyp2c19 substrates
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories antidepressive agents, tricyclic
    Drug Categories antidepressive agents
    Drug Categories alpha1 antagonists
    Drug Categories adrenergic uptake inhibitors
    Drug Categories adrenergic agents
    Drug Groups approved
    Drug Type small molecule
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Serotonin 2c (5-HT2c) receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Histamine H1 receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Dopamine D2 receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Adrenergic receptor alpha-1 antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Adrenergic receptor alpha-1 antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Norepinephrine transporter inhibitor
    Direct Interaction yes

    Publications: